China Universal Asset Management Company’s bluebird bio BLUE Stock Holding History

China Universal Asset Management Company’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,831	Closed	-$19K	–	501
2024 Q3	$19K	Buy	1,831 +713	+64%	+$11.9K	﹤0.01%	405
2024 Q2	$22K	Sell	1,118 -711	-39%	-$14.2K	﹤0.01%	390
2024 Q1	$46.8K	Buy	1,829 +1,197	+189%	+$30.7K	0.01%	414
2023 Q4	$17.5K	Buy	632 +495	+361%	+$30.2K	﹤0.01%	412
2023 Q3	$8.35K	Buy	137 +67	+96%	+$4.71K	﹤0.01%	358
2023 Q2	$4.59K	Hold	70	–	–	﹤0.01%	380
2023 Q1	$4.44K	Buy	70 +28	+67%	+$3.2K	﹤0.01%	380
2022 Q4	$5.83K	Buy	42 +6	+17%	+$845	﹤0.01%	281
2022 Q3	$5K	Buy	+36	New	+$4.07K	﹤0.01%	267

Other funds holding BLUE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

China Universal Asset Management Company's BLUE Position: Q4 2024 in Review

China Universal Asset Management Company sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,831 shares — an estimated $19K sold.

China Universal Asset Management Company first reported a position in BLUE in Q3 2022 and held it in 9 quarters. The position peaked at $46.8K in Q1 2024. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

China Universal Asset Management Company reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
China Universal Asset Management Company sold 1,831 bluebird bio shares in Q4 2024, an estimated $19K.
China Universal Asset Management Company first reported a position in bluebird bio in Q3 2022 and held it in 9 quarters.
China Universal Asset Management Company's bluebird bio position peaked at $46.8K in Q1 2024.
83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.